PAPA & BARKLEY Trademark

Trademark Overview


On Monday, February 25, 2019, a trademark application was filed for PAPA & BARKLEY with the United States Patent and Trademark Office. The USPTO has given the PAPA & BARKLEY trademark a serial number of 88314250. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, July 8, 2024. This trademark is owned by Egg Rock Holdings, LLC. The PAPA & BARKLEY trademark is filed in the Cosmetics & Cleaning Products and Pharmaceutical Products categories with the following description:

Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabichromene solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabielsoin solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of fore...

Essential oils for cosmetic purposes, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Essential oils for cosmetic purposes, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa ...
papa & barkley

General Information


Serial Number88314250
Word MarkPAPA & BARKLEY
Filing DateMonday, February 25, 2019
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, July 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 26, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized wording "PAPA & BARKLEY" in blue. In between the words "PAPA" and "BARKLEY" is the ampersand sitting inside a blue outline of a circle with a narrow blue leaf running through the ampersand. The white in the drawing is for background areas only and is not a feature of the mark.
Goods and ServicesOrally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabichromene solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabielsoin solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabinol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabinodiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabidiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabicitran solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabimovone solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabichromene solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabielsoin solely derived from Cannabis sativa L. with a delta9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabinol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabinodiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabidiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabicitran solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabimovone solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabichromene solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabielsoin solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabinol solely derived from Cannabis sativa L. with a delta9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabinodiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabidiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabicitran solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabimovone solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient, all of the foregoing containing no cannabis and no cannabinoids
Pseudo MarkPAPA AND BARKLEY
Goods and ServicesEssential oils for cosmetic purposes, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Essential oils for cosmetic purposes, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils in drop form, capsule form, and liquid form, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils in drop form, capsule form, and liquid form, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments in drop form and liquid form, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments in drop form and liquid form, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Non-medicated body soaks, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Nonmedicated body soaks, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Electronic cigarette liquid (e-liquid) comprised of essential oils, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Electronic cigarette liquid (e-liquid) comprised of essential oils, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Indication of Colors claimedThe color(s) BLUE is/are claimed as a feature of the mark.

Classification Information


International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 15, 2019
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMAMMOTH MANAGEMENT, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNORTH HOLLYWOOD, CA 91605

Party NameEgg Rock Holdings, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGlendale, CA 91206

Party NameEgg Rock Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGlendale, CA 91206

Trademark Events


Event DateEvent Description
Thursday, February 28, 2019NEW APPLICATION ENTERED
Friday, March 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 21, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, May 6, 2019ASSIGNED TO EXAMINER
Monday, May 6, 2019ASSIGNED TO EXAMINER
Tuesday, October 29, 2019NON-FINAL ACTION E-MAILED
Tuesday, October 29, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 28, 2019ASSIGNED TO EXAMINER
Tuesday, October 29, 2019NON-FINAL ACTION WRITTEN
Wednesday, April 29, 2020DIVISIONAL REQUEST RECEIVED
Monday, May 11, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 29, 2020TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, April 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 4, 2020ASSIGNED TO LIE
Monday, May 11, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 11, 2020DIVISIONAL PROCESSING COMPLETE
Saturday, June 13, 2020FINAL REFUSAL E-MAILED
Saturday, June 13, 2020FINAL REFUSAL WRITTEN
Saturday, June 13, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, December 14, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, December 14, 2020TEAS REQUEST TO DIVIDE RECEIVED
Sunday, December 13, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, December 14, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, December 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 14, 2020DIVISIONAL REQUEST RECEIVED
Monday, December 14, 2020EXPARTE APPEAL RECEIVED AT TTAB
Monday, December 14, 2020EX PARTE APPEAL-INSTITUTED
Monday, December 14, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, December 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 23, 2020DIVISIONAL PROCESSING COMPLETE
Tuesday, December 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 23, 2020DIVISIONAL PROCESSING COMPLETE
Monday, April 26, 2021NON-FINAL ACTION WRITTEN
Friday, October 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 26, 2021NON-FINAL ACTION E-MAILED
Monday, April 26, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 22, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 14, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, April 14, 2022SUBSEQUENT FINAL REFUSAL WRITTEN
Thursday, April 14, 2022SUBSEQUENT FINAL EMAILED
Thursday, April 14, 2022NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Wednesday, June 29, 2022JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, October 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 20, 2022ASSIGNED TO LIE
Saturday, February 25, 2023ACTION CONTINUING FINAL - COMPLETED
Saturday, February 25, 2023ACTION DENYING REQ FOR RECON E-MAILED
Saturday, February 25, 2023NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, May 2, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, November 20, 2023EXPARTE APPEAL TERMINATED
Wednesday, December 6, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 26, 2023PUBLISHED FOR OPPOSITION
Monday, November 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 26, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 8, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 8, 2024SOU EXTENSION 1 GRANTED
Monday, July 8, 2024SOU EXTENSION 1 FILED
Thursday, August 29, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, September 13, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 13, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 13, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS